HB 4457 prohibits pharmacy benefits managers (PBMs) from owning or controlling pharmacy licenses in Oklahoma. The State Board of Pharmacy must revoke licenses of violators after November 2026, though it may issue temporary licenses for rare, orphan, or limited-distribution drugs until September 2028. Pharmacies must notify patients of service changes by January 2027, and the Board must provide lists of compliant pharmacies. This law prevents conflicts of interest by restricting PBMs from owning pharmacies.
This bill proposes a constitutional amendment to establish the "Tobacco Settlement Endowment Trust Fund" for Oklahoma's tobacco settlement funds. It requires that at least 75% of new tobacco settlement payments (after 2001) be deposited into this trust fund, with specific percentages increasing over time. The trust fund's earnings must be used for cancer research, tobacco prevention programs, children's health initiatives, senior care programs, and education-related expenses, with unused funds remaining in the trust. The amendment creates two governing boards to manage investments and allocate funds, and it would require voter approval before taking effect.
SB 1847 modifies Oklahoma's ADvantage Waiver Program, which provides Medicaid home- and community-based services. It creates an exception allowing individuals with cognitive impairments to qualify if they were already residing in an assisted living center contracted with the state when their impairment developed, and the center has a specific accommodation plan. This change directly affects adults with cognitive impairments who live in state-contracted assisted living facilities and developed their condition after moving in. The bill does not alter financial or age requirements but adjusts eligibility for this specific group. The exception applies to those meeting all three conditions outlined in the bill's new subsection B.
HB 4421 requires Oklahoma's Department of Human Services (DHS) to conduct a safety analysis within 24 hours when a child is suspected of being "drug-endangered" (e.g., due to fentanyl exposure or substance use by caregivers). It mandates drug screening - including mandatory fentanyl testing - for parents or caregivers when substance use is suspected, and allows DHS to seek court orders if consent is refused. The bill also creates a "Child Welfare Fentanyl Testing Revolving Fund" to cover testing costs and requires DHS to refer certain abuse/neglect cases to law enforcement. These provisions directly affect children in welfare cases, their caregivers, DHS staff, and local law enforcement agencies.
HB 2947 adds a new provider code in Oklahoma Medicaid for master's and doctoral-level behavioral health clinical interns. These interns - graduate students in nationally accredited programs - can provide services under the direct supervision of licensed behavioral health providers (like LPCs or LCSWs) while following all Medicaid documentation and training requirements. The bill directly affects interns seeking practical experience and licensed supervisors who will oversee their Medicaid-covered services. It expands Medicaid access to behavioral health care by formalizing intern participation in the state's Medicaid plan.
HB 3345 requires mandatory mental health, substance abuse, and risk screenings for individuals arrested on felony charges in Oklahoma after their initial court appearance. These screenings, conducted by certified professionals from the Department of Mental Health, must be shared with courts, prosecutors, defendants, and their attorneys. Results cannot be used as evidence in criminal trials unless the defendant waives this right, but may inform sentencing or diversion options. The law takes effect November 1, 2026.
HB 3645 amends Oklahoma's hospice care requirements to expand eligibility determination options when patients lack legal representatives. It allows hospice admission decisions by a licensed long-term care administrator (with 6 months oversight and two physician approvals), two physicians reviewing medical history, or a primary care physician managing care for six months. The bill maintains existing standards like 24/7 care, bereavement programs, and prohibitions on improper patient solicitation. It directly affects hospice providers and patients without appointed guardians, ensuring timely access to hospice services under defined criteria.
SB 2074 requires pharmacy benefit managers (PBMs) to accept all documentation from pharmacies when challenging reimbursement amounts and include specific details in appeal requests. If an appeal is approved, PBMs must adjust payments within 14 days and provide claim-level details. The bill applies to all PBMs working with Oklahoma pharmacies and covers disputes over reimbursement rates for prescription drugs. It aims to streamline the appeals process and prevent delays in payments to pharmacies.
HB 3544 prohibits AI chatbots with human-like features (e.g., claiming sentience or seeking emotional bonds) from being available to minors under 18. It requires developers to implement age verification systems and offer alternative versions without such features for minors. Therapeutic chatbots providing mental health support are exempt if they include clear disclaimers, require professional oversight, provide clinical evidence of safety, and maintain transparency. Violations could result in civil penalties up to $7,500 per intentional violation, with minors or parents able to seek damages of $100-$750 per incident. The law takes effect November 1, 2026.
HB 3127 protects Oklahoma medical marijuana patients and caregivers from discrimination in employment, public assistance, and firearm ownership. It prohibits employers from refusing to hire, firing, or penalizing individuals solely for being a licensed medical marijuana user, and bars denial of Medicaid, SNAP, or firearm rights based on that status. However, the bill mandates a "zero-tolerance" policy for safety-sensitive jobs (like operating vehicles, handling hazardous materials, or direct patient care), allowing employers to enforce drug testing and discipline for marijuana use at work. Employers may still maintain written drug testing policies under state standards, but cannot deny employment based solely on medical marijuana license status or a positive test if the user is licensed and not impaired at work.
